These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11234273)

  • 1. [Side effects of non-steroid anti-inflammatory drugs in rheumatic patients].
    Komarov VT; Khichina NS; Devina OV; Nikishina AIu
    Klin Med (Mosk); 2001; 79(1):60. PubMed ID: 11234273
    [No Abstract]   [Full Text] [Related]  

  • 2. [NSAID prescription in patients with rheumatoid arthritis and cardiovascular disease].
    Pavlović R; Curković B; Babić-Naglić D; Kehler T
    Reumatizam; 2006; 53(1):22-4. PubMed ID: 17580545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperpermeability of the small intestine mucosa after prolonged application of non-steroidal anti-inflammatory drugs in patients with rheumatic diseases].
    Lebedeva VV; Gmoshinskiĭ IV; Mazo VK; Murav'ev IuV
    Eksp Klin Gastroenterol; 2008; (2):16-21. PubMed ID: 19148987
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe neutropenia due to naproxen therapy in rheumatoid arthritis: a case report and review of literature.
    Kalksma R; Jansen TL; Bruyn GA
    Neth J Med; 2002 Aug; 60(7):289-91. PubMed ID: 12430576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The safety profile of anti-rheumatic drugs in long-term use].
    Kurowski M
    Verh Dtsch Ges Inn Med; 1989; 95():704-6. PubMed ID: 2603506
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erosive enteropathy in a patient with polyarthritis].
    Bogas M; Afonso Mdo C; Araújo D
    Acta Reumatol Port; 2006; 31(4):349-54. PubMed ID: 17334047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of conventional drugs and biologic agents for Rheumatoid Arthritis.
    Amoroso A; Gigante A; Gianni C; Amoroso D; Zennaro D; Galluzzo S; Caccavo D
    Eur Rev Med Pharmacol Sci; 2003; 7(5):139-45. PubMed ID: 15214589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-modifying drugs in rheumatoid arthritis.
    Rahman A; Ahmed S; Underwood M
    Practitioner; 2001 Dec; 245(1629):1018-25. PubMed ID: 11771221
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-rheumatic agents: when--which ones?].
    Miehlke K
    Verh Dtsch Ges Inn Med; 1990; 96():182-7. PubMed ID: 2128724
    [No Abstract]   [Full Text] [Related]  

  • 10. What do patients in rheumatologic care know about the risks of NSAIDs?
    Ornbjerg LM; Andersen HB; Kryger P; Cleal B; Hetland ML
    J Clin Rheumatol; 2008 Apr; 14(2):69-73. PubMed ID: 18391673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side effects of antirheumatic therapy on the gastrointestinal tract].
    Voigt J; Kaesberger W; Grün M
    Z Rheumatol; 1987; 46 Suppl 1():76-82. PubMed ID: 3326365
    [No Abstract]   [Full Text] [Related]  

  • 12. Turkish patients with osteoarthritis: their awareness of the side effects of NSAIDs.
    Yilmaz H; Gürel S; Ozdemir O
    Turk J Gastroenterol; 2005 Jun; 16(2):89-92. PubMed ID: 16252199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening patients on long term non-steroidal anti-inflammatory drugs (NSAIDs) for nephrotoxicity--why necessary and how frequently?
    Chogle AR
    J Assoc Physicians India; 2003 Nov; 51():1041-2. PubMed ID: 15260384
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
    Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
    Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against non-steroidal induced upper gastrointestinal side effects.
    Roth SH
    Ann Rheum Dis; 1992 Jan; 51(1):141; author reply 143. PubMed ID: 1540027
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
    Eisen GM; Goldstein JL; Hanna DB; Rublee DA
    Aliment Pharmacol Ther; 2005 Mar; 21(5):591-8. PubMed ID: 15740543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musculoskeletal disorders. Non-steroidal anti-inflammatory drugs.
    Gøtzsche PC
    Clin Evid; 2003 Jun; (9):1292-300. PubMed ID: 12967421
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-rheumatic drugs.
    Baillieres Clin Rheumatol; 1988 Aug; 2(2):275-518. PubMed ID: 3224378
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimal change nephrotic syndrome associated with non steroidal antiinflammatory drugs. A need for careful evaluation.
    Labeeuw M; Cabanne JF; Dubot P
    Clin Nephrol; 1987 Mar; 27(3):162. PubMed ID: 3568464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.